[1]
M. Bellone, L. Pradelli, and M. Bo, “Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation”, FE, vol. 19, no. 1, Feb. 2018.